Following children with developmental disorders through an intensive rehabilitation program
Observes daily abilities in children aged 4 to 12 during a 2-week intensive program.
Key facts
- Who runs it
- Healing Hope International
- Where
- The Woodlands, United StatesSee the site
- Trial code
- Registry title
- Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disorders
- Status
- Recruiting
- People taking part
- 100 people, planned
- Started
- 1 Mar 2026
- Expected to end
- 30 Dec 2036
- Type of study
- Observational
- Record updated
- 25 March 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for children aged about 4 to 12 with neurodevelopmental, neurologic or genetic conditions. They must have trouble in at least one area of development and join a two-week intensive therapy program.
- Age
- About 4 to 12 years old at enrollment
- Sex
- All
- Disease stage
- Neurodevelopmental, neurologic or genetic conditions, such as cerebral palsy, autism spectrum disorder, developmental delay, hypoxic ischemic encephalopathy (HIE), traumatic brain injury, sensory processing disorder, or chromosomal or genetic abnormalities. The child must have difficulty in one or more areas, such as movement, sensory processing, attention, vision, communication, emotions or behavior, or daily activities.
Main reasons for not taking part
- Medical instability or an acute medical condition that makes an intensive therapy program unsafe
- Severe uncontrolled seizures or another neurologic condition that gets in the way of structured therapy
- Behavioral or psychological conditions that prevent safe participation despite support
- Cannot attend or complete the full two-week program
- Taking part in another structured therapy or study that could confuse the results
The registry criteria, word for word
Show all 16 criteriaShow less
Who can take part
- Pediatric participants between approximately 4 and 12 years of age at the time of enrollment
- Diagnosed with or presenting with neurodevelopmental, neurologic, or genetic conditions, including but not limited to:; cerebral palsy; autism spectrum disorder; developmental delay; hypoxic ischemic encephalopathy (HIE); traumatic brain injury; sensory processing disorder; chromosomal or genetic abnormalities; Demonstrate functional impairments in one or more neurodevelopmental domains, including:
- motor coordination or motor planning
- sensory processing
- attention or executive functioning
- oculomotor or visual processing
- communication
- emotional or behavioral regulation
- activities of daily living
- Enrolled in and able to participate in a two-week intensive therapy program consisting of approximately 2.5 hours per day/ 5 days per week; Able to complete baseline and post-program clinical assessment using clinician-observed or caregiver-reported measures; Parent or legal guardian able to provide informed consent and participate in reporting functional outcomes when applicable
Who cannot take part
- Concurrent participation in another structured intervention or clinical study that would confound interpretation of functional outcomes, at the discretion of the investigator
- Medical instability or acute medical condition that would prevent safe participation in an intensive therapy program
- Severe uncontrolled seizure activity or other neurologic condition that would interfere with participation in structured therapeutic activities, as determined by the treating clinician
- Behavioral or psychological conditions that would prevent safe engagement in the therapy environment despite appropriate support
- Inability to attend or complete the full two-week intensive program
- Lack of sufficient baseline or post-intervention data to assess change in functional performance
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 4 and 12 years old?
Where in United States
- Ability and BeyondThe Woodlands, United StatesContact: Dr. Tina Casoglos-Adamopoulos, OT, OTD, BCPTaking people
About the trial
What the trial wants to find out
This observational study evaluates functional and developmental outcomes in pediatric participants undergoing a two week intensive multimodal neurorehabilitation program. The program is designed for children with neurodevelopmental disorders, including but not limited to cerebral palsy, autism spectrum disorder, developmental delay, hypoxic ischemic encephalopathy (HIE), and chromosomal or genetic abnormalities.
Read full original descriptionShow less
Participants receive individualized therapy sessions for approximately 2.5 hours per day over a two week period. The intervention is not standardized but is tailored to each child's specific needs and may include components such as sensory integration, motor planning, reflex integration, oculomotor training, executive functioning activities, communication support, and other brain based therapeutic approaches.
The purpose of this study is to observe changes in functional abilities, including attention, motor coordination, emotional regulation, communication, and activities of daily living. Outcomes are assessed using clinician observation and parent reported changes before and after the intensive program, with limited follow-up when available.
This study does not assign participants to a specific treatment as part of a research protocol. Instead, it collects real world data from children already participating in a clinical therapy program to better understand potential benefits of intensive, individualized neurorehabilitation approaches.
The group in the trial
- Pediatric Intensive Multimodal Neurorehabilitation Cohort
This cohort includes pediatric participants with neurodevelopmental disorders, including cerebral palsy, autism spectrum disorder, developmental delay, hypoxic ischemic encephalopathy, traumatic brain injury, and genetic or chromosomal abnormalities, who are enrolled in a two-week intensive multimodal neurorehabilitation program. Participants receive individualized therapy for approximately 2.5 hours per day, 5 days per week, for 2 consecutive weeks. The intervention is not standardized and is tailored to each participant's clinical needs. Therapy may include sensory integration, motor planning, reflex integration, oculomotor training, auditory processing activities, executive functioning tasks, communication support, emotional regulation strategies, and other neurodevelopmental approaches. Additional modalities such as tactile stimulation, vibration, and photobiomodulation may be utilized at the discretion of the treating clinician.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Functional and Neurodevelopmental Outcomes Following Intensive Multimodal Neurorehabilitation in Pediatric Patients With Neurodevelopmental Disorders, Including Chromosomal Abnormalities
- Plain-language title
- Following children with developmental disorders through an intensive rehabilitation programGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT07493096, who can take part
- Record updated
- 25 March 2026